SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3042% above fair value
$23.16−0.25 (-1.07%)
Close on Nov 17, 2026Market cap $1.04BP/E –Yield 0.00%
Si-Bone total assets
Total assets on the balance sheet at the end of each period.
Si-Bone's total assets was $248.76M at Jun 30, 2026. For fiscal 2025 it was $238.56M, up 3.5% from the year before. The highest annual figure on record is $238.56M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $238.56M | +3.5% |
| FY2024 | Dec 31, 2024 | $230.44M | +0.0% |
| FY2023 | Dec 31, 2023 | $230.43M | +46.3% |
| FY2022 | Dec 31, 2022 | $157.55M | -17.3% |
| FY2021 | Dec 31, 2021 | $190.51M | -14.6% |
| FY2020 | Dec 31, 2020 | $223.14M | +90.7% |
| FY2019 | Dec 31, 2019 | $117.01M | -15.5% |
| FY2018 | Dec 31, 2018 | $138.52M | +286.6% |
| FY2017 | Dec 31, 2017 | $35.83M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $248.76M | +7.7% |
| Q1 FY2026 | Mar 31, 2026 | $242.72M | +6.8% |
| Q4 FY2025 | Dec 31, 2025 | $238.56M | +3.5% |
| Q3 FY2025 | Sep 30, 2025 | $234.27M | +3.2% |
| Q2 FY2025 | Jun 30, 2025 | $230.92M | +3.2% |
| Q1 FY2025 | Mar 31, 2025 | $227.28M | +1.6% |
| Q4 FY2024 | Dec 31, 2024 | $230.44M | +0.0% |
| Q3 FY2024 | Sep 30, 2024 | $227.00M | -1.7% |
| Q2 FY2024 | Jun 30, 2024 | $223.84M | -4.3% |
| Q1 FY2024 | Mar 31, 2024 | $223.71M | +50.1% |
| Q4 FY2023 | Dec 31, 2023 | $230.43M | +46.3% |
| Q3 FY2023 | Sep 30, 2023 | $230.88M | +45.9% |
| Q2 FY2023 | Jun 30, 2023 | $233.83M | +40.7% |
| Q1 FY2023 | Mar 31, 2023 | $149.08M | -15.7% |
| Q4 FY2022 | Dec 31, 2022 | $157.55M | -17.3% |
| Q3 FY2022 | Sep 30, 2022 | $158.27M | -18.4% |
| Q2 FY2022 | Jun 30, 2022 | $166.15M | -19.9% |
| Q1 FY2022 | Mar 31, 2022 | $176.85M | -18.0% |
| Q4 FY2021 | Dec 31, 2021 | $190.51M | -14.6% |
| Q3 FY2021 | Sep 30, 2021 | $193.97M | +25.7% |
| Q2 FY2021 | Jun 30, 2021 | $207.33M | +30.2% |
| Q1 FY2021 | Mar 31, 2021 | $215.76M | +28.6% |
| Q4 FY2020 | Dec 31, 2020 | $223.14M | +90.7% |
| Q3 FY2020 | Sep 30, 2020 | $154.32M | +27.2% |
| Q2 FY2020 | Jun 30, 2020 | $159.25M | +25.3% |
| Q1 FY2020 | Mar 31, 2020 | $167.82M | +27.1% |
| Q4 FY2019 | Dec 31, 2019 | $117.01M | -15.5% |
| Q3 FY2019 | Sep 30, 2019 | $121.32M | +327.2% |
| Q2 FY2019 | Jun 30, 2019 | $127.12M | +254.8% |
| Q1 FY2019 | Mar 31, 2019 | $132.05M | – |
| Q4 FY2018 | Dec 31, 2018 | $138.52M | – |
| Q3 FY2018 | Sep 30, 2018 | $28.40M | – |
| Q4 FY2017 | Dec 31, 2017 | $35.83M | – |
See a number that looks wrong?